These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 27644253)

  • 1. Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.
    Peng F; Xiong L; Tang H; Peng C; Chen J
    Tumour Biol; 2016 Nov; 37(11):14463-14477. PubMed ID: 27644253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs regulate the epithelial-mesenchymal transition and influence breast cancer invasion and metastasis.
    Zhao M; Ang L; Huang J; Wang J
    Tumour Biol; 2017 Feb; 39(2):1010428317691682. PubMed ID: 28222665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis.
    Chen W; Zhou S; Mao L; Zhang H; Sun D; Zhang J; Li J; Tang JH
    Tumour Biol; 2016 Aug; 37(8):10011-9. PubMed ID: 27153853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.
    De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L
    Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A summary for molecular regulations of miRNAs in breast cancer.
    Yahya SM; Elsayed GH
    Clin Biochem; 2015 Apr; 48(6):388-96. PubMed ID: 25541018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
    Xia H; Hui KM
    Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
    Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-497 inhibits epithelial mesenchymal transition in breast carcinoma by targeting Slug.
    Wu Z; Li X; Cai X; Huang C; Zheng M
    Tumour Biol; 2016 Jun; 37(6):7939-50. PubMed ID: 26700673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer.
    Behbahani GD; Ghahhari NM; Javidi MA; Molan AF; Feizi N; Babashah S
    Pathol Oncol Res; 2017 Jan; 23(1):1-12. PubMed ID: 27590333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
    Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-182 drives colonization and macroscopic metastasis via targeting its suppressor SNAI1 in breast cancer.
    Zhan Y; Li X; Liang X; Li L; Cao B; Wang B; Ma J; Ding F; Wang X; Pang D; Liu Z
    Oncotarget; 2017 Jan; 8(3):4629-4641. PubMed ID: 27894095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer.
    Chu S; Liu G; Xia P; Chen G; Shi F; Yi T; Zhou H
    Oncol Rep; 2017 Oct; 38(4):2401-2407. PubMed ID: 28765915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNAs 484 and 210 regulate Pax-5 expression and function in breast cancer cells.
    Harquail J; LeBlanc N; Ouellette RJ; Robichaud GA
    Carcinogenesis; 2019 Aug; 40(8):1010-1020. PubMed ID: 30605519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in colorectal cancer metastasis.
    de Krijger I; Mekenkamp LJ; Punt CJ; Nagtegaal ID
    J Pathol; 2011 Aug; 224(4):438-47. PubMed ID: 21706478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in Epithelial-Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy.
    Peng F; Fan H; Li S; Peng C; Pan X
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of miR-155 in drug resistance of breast cancer.
    Yu DD; Lv MM; Chen WX; Zhong SL; Zhang XH; Chen L; Ma TF; Tang JH; Zhao JH
    Tumour Biol; 2015 Mar; 36(3):1395-401. PubMed ID: 25744731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis.
    Harquail J; Benzina S; Robichaud GA
    Cancer Biomark; 2012; 11(6):269-80. PubMed ID: 23248185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of microRNAs in cancer metastasis.
    Bouyssou JM; Manier S; Huynh D; Issa S; Roccaro AM; Ghobrial IM
    Biochim Biophys Acta; 2014 Apr; 1845(2):255-65. PubMed ID: 24569228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.